The stock market recorded stellar year-end returns when markets closed on Wednesday for the last time in 2025. The performance marked three straight years
Latest News
Stock Market Today, Dec. 31: Plug Power Rises After Clear Street Upgrades Rating Despite Lower Price Target
Today, Dec. 31, 2025, a cautious analyst upgrade spotlights Plug Power’s high‑risk hydrogen turnaround and funding puzzle. Plug Power Today’s Change (1.55%) $0.03 Current
Wall Street falls in light trading on the final day of 2025, another banner year for markets
Wall Street closed out another banner year for stocks Wednesday with a downbeat finish that extended the market’s recent losing streak to a fourth
Stock Market Today, Dec. 31: Lackluster Year End Barely Dents 2025's Double Digit Gains
On Dec. 31, 2025, profit‑taking in high‑growth names and fading AI buzz dragged major U.S. benchmarks lower into a thin year‑end close. After a
Jim Cramer Thinks Amazon Stock’s a Buy After Doing Nothing All Year. Why He’s Absolutely Right.
© jetcityimage / iStock Editorial via Getty Images Mad Money host Jim Cramer doesn’t yet appear ready to give up on shares of Amazon
Stock market today: Dow, S&P 500, Nasdaq post double-digit gains in 2025 as AI trade powers market once again
Stocks fell slightly during the final trading session of an eventful 2025 that saw the S&P 500 clinch a third-straight double-digit gain and the
Global outlook for 2026 – Defying gravity?
THE year 2025 marked the end of the initial phase of global economic adjustments. The global economy performed much better than feared, cruising at
5 Reasons Why Disney Stock Will Beat the Market in 2026
The House of Mouse could be a penthouse for investors in the year ahead. The last couple of years haven’t been easy for Walt
These Are The 3 Stock Split Candidates Heading Into 2026
© XtockImages / iStock via Getty Images Stock splits don’t change a company’s intrinsic value, but they generate a lot of attention among investors.
US Stock Market Today: S&P 500 and NASDAQ 100 Trade Flat as Jobless Claims Decline and Dollar Struggles
Single-stock moves reflected event-driven trading. Vanda Pharmaceuticals surged after the US FDA approved its motion-sickness treatment tradipitant. Axsome Therapeutics jumped after its Alzheimer’s drug